Entero Healthcare Solutions Updates Committees and Releases Q1 2026 Financial Results
Entero Healthcare Solutions Limited announced significant governance updates and released its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved both standalone and consolidated financial results, which were reviewed by the Statutory Auditors and reported as unmodified.The company also reconstituted key operational committees within the Board of Directors with effect from August 25, 2026. This reconstitution followed the completion of Rajesh Shashikant Dalal's tenure as a Non-Executive Independent Director. The committees are detailed below:
Reconstituted Board Committees (Effective August 25, 2026)
| Committee | Chairperson/Member Details |
|---|---|
| Audit Committee | Sandhya Gadkari Sharma (Chairperson), Sujesh Vasudevan (Member), Prabhat Agrawal (Managing Director & CEO) (Member). |
| Nomination and Remuneration Committee | Sandhya Gadkari Sharma (Chairperson), Sujesh Vasudevan (Member), Arun Sadhanandham (Non-Executive Nominee Director) (Member). |
| Stakeholders Relationship Committee | Sujesh Vasudevan (Chairperson), Arun Sadhanandham (Non-Executive Nominee Director) (Member), Prem Sethi (Whole Time Director & COO) (Member). |
Unaudited Financial Performance Highlights (Quarter ended June 30, 2026)
The unaudited standalone financial results show Total Income of Rs. 1,064.11 million, compared to Total Expenses of Rs. 1,018.06 million for the quarter. The profit for the period stood at Rs. 34.57 million.A detailed comparison of key metrics in millions (Rs.) is provided below:
| Particulars | Q ended June 30, 2026 (Unaudited) | Q ended March 31, 2026 (Audited) | Q ended June 30, 2025 (Unaudited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 832.66 | 789.32 | 793.52 | 3,482.41 |
| Other income | 231.45 | 399.56 | 262.88 | 1,137.23 |
| Total Income | 1,064.11 | 1,188.88 | 1,056.40 | 4,619.64 |
| Total Expenses | 1,018.06 | 1,068.50 | 964.76 | 4,272.81 |
| Profit before tax | 46.05 | 120.38 | 91.64 | 346.83 |
| Total tax expenses | 11.48 | (13.78) | 22.07 | 33.11 |
| Profit for the period | 34.57 | 134.16 | 69.57 | 268.75 |
Consolidated Financial Results Snapshot (Quarter ended June 30, 2026)
The unaudited consolidated financial results for the Group showed Total Income of Rs. 19,435.02 million and total expenses of Rs. 18,763.82 million. Profit attributable to the owners of the Company was reported at Rs. 381.62 million.| Particulars | Q ended June 30, 2026 (Unaudited) | Q ended March 31, 2026 (Audited) | Q ended June 30, 2025 (Unaudited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Total income | 19,435.02 | 19,139.35 | 14,096.44 | 66,104.49 |
| Total Expenses | 18,763.82 | 18,559.88 | 13,732.81 | 64,229.35 |
| Profit before tax | 671.20 | 579.47 | 363.63 | 1,793.36 |
| Total tax expenses | 150.69 | 128.19 | 61.31 | 334.96 |
| Profit for the period | 520.51 | 451.28 | 302.32 | 1,458.40 |
| Profit attributable to owners of the Company | 381.62 | 280.09 | 277.99 | 1,150.42 |
Corporate Activities and Subsidies
During the quarter ended June 30, 2026, the company allotted 12,135 equity shares of Rs. 10 each at a premium of Rs. 794 per share, aggregating to Rs. 9.76 million pursuant to employee stock option exercise. Furthermore, Sai Pharma Distributors Private Limited entered into a business transfer agreement with Vishal Surgical and Vishat Surgicals & Medicals, a transaction anticipated to be completed by December 31, 2026.The Group operates in one segment: trading of pharmaceutical and surgical products. The company has numerous subsidiaries, including Wholly Owned Subsidiaries like Saurashtra Medisolutions Private Limited, Sri Parshva Pharma Distributors Private Limited, and S.S. Pharma Traders Private limited among others.
ENTERO Stock Price Movement
Entero Healthcare Solutions Limited shares slipped slightly on Friday, settling at ₹1242.70 after shedding 0.04% in market close. The stock recorded a daily volume of 46,032 as it concluded trading for the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.